Dr. Amit Kulkarni, MD
Claim this profileUniversity of Minnesota
Studies Colitis
Studies Inflammatory Bowel Disease
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Amit Kulkarni, MD is currently running
More about Amit Kulkarni, MD
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical TrialTreatments Amit Kulkarni, MD has experience with
- Placebo
- RMT
- Pembrolizumab
Breakdown of trials Amit Kulkarni, MD has run
Colitis
Inflammatory Bowel Disease
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amit Kulkarni, MD specialize in?
Amit Kulkarni, MD focuses on Colitis and Inflammatory Bowel Disease. In particular, much of their work with Colitis has involved Stage IV patients, or patients who are undergoing treatment.
Is Amit Kulkarni, MD currently recruiting for clinical trials?
Yes, Amit Kulkarni, MD is currently recruiting for 1 clinical trial in Minneapolis Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Amit Kulkarni, MD has studied deeply?
Yes, Amit Kulkarni, MD has studied treatments such as Placebo, RMT, Pembrolizumab.
What is the best way to schedule an appointment with Amit Kulkarni, MD?
Apply for one of the trials that Amit Kulkarni, MD is conducting.
What is the office address of Amit Kulkarni, MD?
The office of Amit Kulkarni, MD is located at: University of Minnesota, Minneapolis, Minnesota 55414 United States. This is the address for their practice at the University of Minnesota.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.